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Obesity and obesity-related complications are on the increase both in the developed and developing world. Since existing pharma-
ceuticalsfailtocomeupwithlong-termsolutionstoaddressthisissue,thereisanever-pressingneedtoﬁndanddevelopnewdrugs
and alternatives. Natural products, particularly medicinal plants, are believed to harbor potential antiobesity agents that can
act through various mechanisms either by preventing weight gain or promoting weight loss amongst others. The inhibition of
key lipid and carbohydrate hydrolyzing and metabolizing enzymes, disruption of adipogenesis, and modulation of its factors or
appetite suppression are some of the plethora of targeted approaches to probe the antiobesity potential of medicinal plants. A new
technology such as metabolomics, which deals with the study of the whole metabolome, has been identiﬁed to be a promising
technique to probe the progression of diseases, elucidate their pathologies, and assess the eﬀects of natural health products on
certain pathological conditions. This has been applied to drug research, bone health, and to a limited extent to obesity research.
This paper thus endeavors to give an overview of those plants, which have been reported to have antiobesity eﬀects and highlight
the potential and relevance of metabolomics in obesity research.
1.Introduction
Obesity is a rapidly growing epidemic worldwide, presenting
an increase in the risk of morbidity and mortality in many
c o u n t r i e sa c r o s st h ew o r l d[ 1]. Today more than 1.1 billion
people are overweight worldwide and 312 million are clas-
siﬁed as obese [2]. The World Health Organization (WHO)
deﬁnes obesity as an abnormal or excessive fat accumulation
detrimental to human health. Complications associated with
obesity, such as hypertension, hyperlipidemia, diabetes mel-
litus, cardiovascular disease, cancer, and metabolic disorders
a r ef o r c i n gr e s e a r c h e r st oc o m eu pw i t hl o n g - t e r ms o l u t i o n s
for weight management and control [3, 4]. Obesity has also
been deﬁned as an increased adipose tissue mass, which is
the result of an enlargement in fat cells and/or an increase in
their number [5]. A crude measure of obesity is the Body
Mass Index (BMI), calculated as body weight in kilogram
dividedbythesquareofheightinmeters.Beingoverweightis
deﬁned as a BMI of 25.0–29.9kgm−2, and a BMI exceeding
30kgm−2 is considered as obese. An extreme obesity is
deﬁned as a BMI of greater than 40kgm−2 [6]. Today, more
than 65% of adults in the United States are overweight or
obese [7]. In developing countries like Malaysia, 23% of the
adult population was found to be overweight and 14% obese
[8].
The main cause of obesity is exceeding energy input over
energyexpenditure.Ourgeneticbuild-up,toacertainextent,
plays a role in determining whether we will suﬀer from
obesity or not at some point of our life. While it is easy to
isolate the gene responsible for obesity in rodents, it is not
the case for humans. About only 33% of the variance in
body weight is due to genetic inﬂuences but environmental
inﬂuences are of great importance. These factors include
lifestyles and socioeconomic factors [9]. The adipose tissue
is not a single entity but consists of several subclasses such
as the visceral and subcutaneous layers, which have diﬀerent2 The Scientiﬁc World Journal
implications for health. The adipose tissue is not only a stor-
age organ for triacylglycerides but also an endocrine organ
where numerous chemical messengers called adipokines are
released for better communication with other tissues [10].
Although reduction of caloric intake by diet and in-
creased level of physical activity are very well-known ap-
proaches to lose weight, the needs for drugs and other sup-
plements are fast gaining acceptance. Many diets have been
advocated for weight loss but there is little scientiﬁc evidence
to recommend one diet over another [6]. Due to the incon-
sistent eﬀort in achieving a negative energy balance through
diet and exercise, the needs for drugs and other supplements
are fast gaining acceptance. However, drug discovery for
antiobesityagentshavelongbeenplaguedwithinconsistency
andsideeﬀects.Thecurrentclinicaltreatmentforobesityisa
synthetic analogue of Lipstatin, Orlistat. Orlistat is reported
to be a potent inhibitor of gastric, pancreatic, and carbox-
ylester lipase [11]. Orlistat is also a gastrointestinal lipase
inhibitor that competes with dietary fats for sites on the
lipase molecules and has been shown to block the absorption
of about 30% of dietary fat at a therapeutic oral dose of
120mg three times a day. Orlistat does not show any appar-
ent eﬀect on appetite [12] but is known to inhibit several
human digestive and metabolic lipases. Orlistat has been
deﬁned as an active site-directed inhibitor that reacts with
the nucleophilic serine residue from the catalytic triad of
pancreatic lipase (PL) [11]. By covalently blocking the active
site, Orlistat inhibits the hydrolysis of dietary triglycerides
and thus reduces the subsequent intestinal absorption of
the lipolysis products monoglycerides and free fatty acids.
Orlistat also inhibits gastric lipase [13] and lipoprotein lipase
(LPL) [14] in vitro. Other means of preventing obesity is
throughappetitesuppression,modulationofadipocytespro-
liferationanddiﬀerentiation,theadipogenicfactors,increase
in thermogenesis, or inhibition of fatty acid synthase (FAS).
The role of medication in weight loss is controversial and
lits eﬀectiveness appears too limited. The Food and Drug
Administration (FDA) has approved no weight loss drug for
use for more than 2 years. Hence drugs represent a short-
term solution for a long-term problem with only modest
beneﬁts and unclear risk(s) [6]. Diets high in fats tend to
promote obesity, hence inhibition of digestion and absorp-
tion of dietary fats is a logical remedy in treating obesity.
As synthetic drugs fail to give desired eﬀects and with side
eﬀects involved, the utilization of traditional and alternative
medicines is fast gaining acceptance. According to the
WHO, in developing countries, medicinal plants contribute
signiﬁcantly to primary health care and herbal medicine
trade is worth US$ 60 million. With more and more people
rejecting chemical drugs due to the fear of side eﬀects,
natural-based products are fast gaining popularity, thus
justifying extensive research in this ﬁeld. The last decade has
seen a lot of improvements in advanced methods used in
systemsbiologyresearch.The“omics”technology:genomics,
proteomics, transcriptomics, and lately metabolomics have
made it possible to validate the use to traditional medicines
scientiﬁcally, identify new bioactive compounds, elucidate
their mechanisms of action, and assess toxicity and quality
control [15].Thispaperaimstodiscussplantsthathavebeen
reported for antiobesity eﬀects and potential of metabolo-
mics in antiobesity research. Plants can be grouped based on
diﬀerent mechanisms of action: enzymes inhibition, mod-
ulation of adipogenesis & adipogenic factors, and appetite
suppression.
2. Enzymes Inhibition
Inhibition of the digestion and absorption of dietary fat has
beenusedastargetinobesitytreatment[16].Itisunderstood
that PL is the most important enzyme responsible for the
digestion of triglycerides into mono and diglycerides and in
smaller fatty acids to be absorbed by the body. Researchers
and health professionals support that an inhibition of PL
can reduce digestion of fats, hence their assimilation and
absorption. This can mimic a reduced calorie intake in obese
patients and help in preventing additional weight gain [4].
Lipoprotein lipase (LPL) has also been targeted in obesity
as it has been found out that there is an increase in LPL
level in obese subjects. Since LPL catalyzes the hydrolysis
of blood triglycerides to release free fatty acids (FFA) and
hence increases the storage of triglycerides in adipose tissue
[17], inhibition of LPL is expected to reduce assimilation of
FFA and help in controlling obesity. Inhibition of enzymes
involved in carbohydrates digestion and metabolism are
preferentially studied in the treatment of type 2 diabetes
mellitus. However, it can also be considered and relevant
in obesity research, owing to the fact that carbohydrates are
major sources of calories in the human diets. Those enzymes
inhibitors slow down carbohydrate metabolism and subse-
quently reducing postprandial hyperglycemia, hence delay-
ing the conversion of glucose in the adipose tissue to
triacylglycerol [18].
A panoply of botanicals have been assessed for their
antilipase activity as a therapy to manage obesity. A com-
prehensive review on lipase inhibitors from natural sources
was published recently [19]. Natural PL inhibitors such as
saponins, polyphenols, terpenes, and microbial by-products
have been described as unexplored potential in the manage-
ment of obesity and new drug discovery. The antiobesity
eﬀect of CT-II, an extract from the edible Nomame herb,
was reported. This extract was found to inhibit porcine PL in
vitro in a dose-dependent manner. A very low concentration
of 0.1mg/mL of the extracts resulted in 50% inhibition of
lipase activity. The feeding of CT-II extract inhibited weight
gain and plasma triglyceride levels in lean rats fed a high-
fat diet, without aﬀecting food intake. In obese subjects,
after 6 months of feeding, weight and total body fat were
signiﬁcantly lost and additional weight gain was suppressed.
Hence, it was concluded from this study that CT-II might
be a powerful lipase inhibitor and could be used as a weight
control in obese subjects [20].
Teas have been long used in Chinese traditional medicine
to treat various ailments such as obesity and lipids disorders.
It is now known that tea saponins, predominantly present in
Oolong tea, have a good inhibitory eﬀect on PL activity, val-
idating the popularity of teas in slimming diets. Tea saponin,
a pancreatic lipase inhibitor, was also found to suppress
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of adipocytes of rodents fed a high-fat diet. The excretion of
triacylglycerol content in the feces was also increased. The
authors suggested that the antiobesity eﬀects of tea saponins
may be mediated through absorption of dietary fat through
an inhibition of PL activity [21]. A standardized Camellia
sinensis L. based drug, AR25 (Exolise), was proposed as an
antiobesity agent. The green tea extract, standardized at 25%
catechin, had direct inhibition on gastric and pancreatic
lipases as well as stimulation of thermogenesis. The eﬀect
of green teas extract was also evaluated in moderately obese
patients. In the clinical trial, after 3 months of consumption
of 375mg catechins, body weight was decreased by 4.6%
and waist circumference by 4.48%. The results showed that
Exolise, with the active component being catechin, can be a
natural antiobesity agent, through its antilipase activity and
increase in thermogenesis [22].
Salacia reticulata is a plant of Indian origin that is com-
monlyusedinJapanasantiobesityandanti-diabeticagent.A
hot-water-soluble extract of S. reticulata (SRHW) was inves-
tigated for its antiobesity eﬀect, both in vitro and in vivo.
SRHW inhibited pancreatic lipase, LPL, and glycerophos-
phate dehydrogenase in vitro. The extract showed no eﬀect
on hormone sensitive lipase. Female Zuker obese rats, fed
on SRHW showed a signiﬁcant decrease in body weight and
fat storage, whereas no signiﬁcant diﬀerence was noted in
males.TheantiobesityeﬀectofSRHWwasattributedtohigh
concentration of polyphenols such as mangiferin, catechins,
and condensed tannins [23].
Grape seed extract (GSE) has also been found to inhibit
LPL in vitro [24]. GSE inhibited PL activity dose depen-
dently, with maximum inhibition of 80%. At a concentration
of 1mg/mL, GSE inhibited LPL activity by 30%. Peanut shell
extracts (PSEs) were found to inhibit various lipases such as
PL, LPL, and hormone-sensitive lipase (HSL). Rats fed on
PSE showed increased fecal excretion of fats, and weight gain
was prevented in rats fed on high diet supplemented with
1% PSE. The increased fecal excretion of lipids suggests that
PSEs work by inhibiting various lipases and might be useful
in inhibiting fat absorption [25].
There is emerging evidence that soy proteins can reduce
body weight. As reviewed by Bhatena and Velaquez [26], the
antiobesity eﬀect of soy protein and its isoﬂavones appears
to be due to the modulation of pancreatic insulin and anti-
oxidative actions and through long-term substitution of
animal proteins by vegetable proteins in low-calorie diet. A
tetrapeptide in soy protein isolate and hydrolysate showed
antiobesity eﬀect in genetically obese mice by reducing
perirenal fat mass and plasma glucose level. The beneﬁcial
eﬀects of this protein food are attributed to its high content
of isoﬂavones mainly genistein and daidzein [26].
We recently reported the inhibitory eﬀect of selected
tropicalplantsfromMalaysiaonlipoprotein lipaseactivityin
vitro. Extracts of Morinda citrifolia fruit (noni), Momordica
charantia (bitter gourd), and Centella asiatica (Asian penny-
wort) were found to inhibit the activity of LPL in vitro. At a
concentration of 0.1mg/mL, Noni fruit extract showed the
highest inhibition of 21.5%, followed by Asian pennywort
extract (18.2%) and bitter gourd extracts (10%). Though the
complete mechanism of inhibition was not reported, it was
suggestedthatthesynergistic eﬀectofseveral ﬂavonoids such
as catechins and epicatechin might have been responsible for
this bioactivity [27].
3. Inhibitorsof Adipogenesis and
Adipogenic Factors
Whiteadiposetissue(WAT)isthemainenergyreserveinhu-
mans and animals, where excess energy is stored as triglycer-
ides. The balance between energy intake and energy out-
put, deﬁned as energy homeostasis and control of body
weight, depends on the equilibrium of this process. An im-
balance between energy intake and energy expenditure has
led to rapid weight gain. The central nervous system, most
speciﬁcally the hypothalamus, regulates and integrates food
intake and energy expenditure, whereas peripheral tissues
such as the muscles and adipose tissue deals with nutrient
metabolism and energy production [28]. A complex net-
work consisting of long-term and short-term signals have
been reported to regulate energy intake. These signals are
integrated by the hypothalamus and involve orexigenic and
anorexigenic neuropeptides that controlappetite andmetab-
olism [29].
During a period of energy deprivation or starvation,
triacylglycerols are mobilized to compensate for the lack of
energy. An excess of WAT has been thought to be one of
the major culprit in the prevalence of obesity in today’s
world [30]. It is known that the growth of the adipose tissue
involves the formation of new adipocytes from precursor’s
cells leading to an increase in the size of the adipocyte. Treat-
mentthatregulatesthesizeandthenumberoftheadipocytes
and the expression of signals involved in energy balance and
the inhibition or enhancement of speciﬁc adipokines have
been suggested to express antiobesity-related bioactivities
[31].
The most common plant implicated in weight loss is
without any doubt green tea. There are various studies
promoting the use of green teas as slimming aids. Recently,
the eﬀect of green tea epigallocatechin gallate (EGCG) was
shown to inhibit the proliferation and diﬀerentiation in the
primary human visceral preadipocytes. The study reported
that the ability of EGCG to promote weight loss can be partly
due to its ability to suppress the number of adipocytes and
a l s os u p p r e s st r i a c y l g l y c e r o l su p t a k e[ 32]. In another study,
supplementation with tea catechins resulted in signiﬁcant
reduction in body weight induced by a high-fat diet as well
as liver and visceral fat accumulation. The stimulation of the
hepatic lipid metabolism by the catechin present in the tea
was suggested to be responsible for the antiobesity eﬀect.
Hence the long-term consumption of tea might be beneﬁcial
for the suppression of diet-induced obesity [33]. Extracts
of Momordica charantia, Centella asiatica, and Morinda
citrifolia inhibited the proliferation on 3T3-L1 preadipocytes
in a dose-dependent manner with Momordica charantia
havingthemosttoxiceﬀectwithanLC50 valueof1.7mg/mL,
followed by Centella asiatica with an LC50 of 2.72mg/mL.
These two extracts also inhibited the diﬀerentiation of
preadipocytes in a time-and dose-dependent manner. These4 The Scientiﬁc World Journal
antiobesity-related bioactivities were again attributed to the
potential synergistic eﬀects of ﬂavonoids [27].
Perilla oil, which is rich in (n-3) polyunsaturated fatty
acids, was found to prevent the excessive growth of visceral
adipose tissue in rats by a downregulation of adipocyte dif-
ferentiation. Perilla oil was found to suppress the late
phase of adipocyte diﬀerentiation and prevention increase
in lipoprotein expression in rats. It was suggested that the
utilization of Perilla oil, rich in α-Linolenic acid chemically
stable, and hence its consumption is good for human to
prevent the development of visceral adipose tissue in obese
patients [34].
Hibiscus sabdariﬀa L., a medicinal plant widely used as
beverage, had also been reported to modulate negatively on
obesity. Studies carried out proved that water extract of this
plant inhibits the adipocyte diﬀerentiation through a mod-
ulation of the P13-K and MAPK pathways that are critical
for adipogenesis to happen [35]. Hibiscus extracts were also
shown to inhibit porcine pancreatic amylase, eﬀective in
decreasing levels of cholesterol, lipids, and triglycerides in
rats and inhibitory eﬀect on adipogenesis in 3T3-L1 pread-
ipocytes [36]. The traditional knowledge combined with
recentscientiﬁcﬁndingssuggeststhatextractsofhibiscuscan
be used as a functional food or alternative medicinal bev-
erages in the management of obesity.
Lemon has also been shown to suppress diet-induced
obesity by suppressing body weight gain and body fat
accumulation. The lemon polyphenols have been shown to
be antiobesity in action by increasing beta oxidation through
upregulation of mRNA level in liver and WAT [37]. An
aqueous extract of Salacia reticulata and cyclodextrin was
foundtoreducetheaccumulationofvisceralfatmass,plasma
triglyceride, and body weight in animals with high fat diet
induced obesity. The anti obesity eﬀects were attributed
to inhibition of carbohydrate and lipid absorption from
small intestine [38]. The eﬀect of lanostane triterpenes from
fruiting bodies of Ganoderma lucidum was investigated on
adipocyte diﬀerentiation in 3T3-L1 cells. As a compound
isolated from Ganoderma lucidum, t-Butyl lucidenate B has
been found to reduce accumulation of triglycerides in 3T3-
L1 adipocytes by 72%. The compound also suppressed
GPDH activity in cells, as well as gene expression of PPAR-
γ, C/EBP-α and SREBP-1c dose dependently [39]. The
antiobesity-related bioactivity of Asian spices was recently
reported [40]. Thirty spices commonly consumed in Asia
wereassessedfortheirantiobesitypotentialthroughdiﬀerent
in vitro assays: adenosine A1 receptor binding, cannabinoid
CB1 binding, and TNF-α and 3T3-L1 adipocytes diﬀerenti-
ation induction. Results revealed that sesame seed and red
chili had high binding activity to the adenosine A1 receptor,
nutmeg, mace, black pepper and turmeric binds predom-
inantly to the cannabinoid CB1 receptor, while piment
and turmeric showed high inhibition of TNF-α accumula-
tion.Majorpurecompoundsisolatedfromtheselectedspices
failed to give similar results, prompting the researchers to
conclude that antiobesity bioactivities of those spices might
be attributed to the minor compounds or a synergistic eﬀect
between compounds [40].
4.AppetiteSuppressants
Fatty acid synthase (FAS) is known to catalyze the reductive
synthesis of long chain fatty acids from acetyl coenzyme A
and malonyl-CoA. It is proven that an inhibition of FAS can
reduce food intake and body weight in mice treated with
FAS inhibitors. This makes the inhibition of FAS a potential
therapeutic target to suppress appetite and induce weight
loss [41]. Many plants and their products have been shown
to inhibit FAS and hence impact negatively on appetite.
Epigallocatechin gallate from green tea was found to be a
strong inhibitor of FAS from chicken liver both by reversible
fast binding and irreversible slow binding. The inhibitory
eﬀects were comparable to that of established FAS inhibitors
such as cerulenin and C75, a synthetic FAS inhibitor [42].
A novel compound from South Africa succulent of the
Hoodiafamilyplanthasbeendocumentedtoreduceappetite
in animals without any sedentary eﬀect. The compound
indentiﬁed as P57 was also tested clinically where it showed
positive results in suppressing appetite and reduced body
weight in obese individuals [43]. In particular, extracts from
Hoodia pilifera and Hoodia gordonii were characterised as
possessing appetite suppressing properties. Oral gavage of
diﬀerent compounds and doses (6.25–50mg/kg) resulted
in decreased food consumption. Compared to fenﬂuramine
control sample, reduction in food intake by compounds
in Hoodia species was greater [44]. Caralluma ﬁmbriata,
an edible cactus used by tribal Indians to suppress hunger
and increase endurance, has shown to be antiobesity in
action. Fifty men and women ingested 1g of Caralluma
extract per day for 60 days. Compared to placebo, the extract
appears to suppress appetite and reduce waist circumference
signiﬁcantly. Feeding of the extractalso resulted in a decrease
in body weight, body mass index, hip circumference, and
bodyfatinoverweightpatients[45].Cathaedulis,commonly
known as khat, is usually chewed after meals in some African
communities. It is known to decrease feeling of hunger and
increase feeling of satiety due to release of cathinone, which
suppresses appetite. Hormones ghrelin and peptide YY
(PYY) are released with hunger and after meal, respectively,
and are known to modulate appetite. The eﬀect of usual
khat chewing for three hours two times was investigated in
6 individuals. The plasma samples were then analysed for
cathinone, ghrelin, and PYY. Results showed that there was
no eﬀect in ghrelin and PYY levels, suggesting that other
mechanisms might be involved in the observed suppression
of appetite. On the other hand, there was an increase in
cathinone levels. Cathinone is explained to have a positive
correlation with satiety and a negative correlation with the
feeling of hunger [46]. Garcinia cambogia is already available
on the market as a dietary supplement to lose weight. The
primary component of the fruit rind is (-)-hydroxycitric acid
(HCA), and supplementation in experimental animals has
showed that HCA can suppress appetite and inhibit body fat
biosynthesis. In rat brain cortex, HCA was shown to increase
availability of 5-hydroxytryptamine or serotonin. This neu-
rotransmitter is implicated in the appetite regulation and
control [47]. A syngergestic eﬀect of diﬀerent herbs to pro-
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(green tea, Coleus forskohlii, yerba mate and Betula alba)
gave a more potent antiobesity eﬀect as compared to the
single entity. The mixture of plants was better than separate
plants in lowering body weight and suppress food intake
in obese rats. The mechanism of action was reported to be
an increase in thermogenesis, antioxidative eﬀect, and the
inhibition of adipocyte proliferation amongst others [48].
5. DietaryPhytochemical Strategies for
ObesityandObesity-LinkedDiseasesUsing
Metabolomic Approaches
Metabolomic is an emerging ﬁeld that promises the ability
to personalize diet in improving health, preventing disease
states, and improving performances. It is deﬁned as the
quantitative measurement of all metabolites in an organism
at a speciﬁed time, under speciﬁc environmental conditions.
Metabolites reﬂect the cellular processes that control the bio-
chemicalreactions of the cell,tissue, orwhole organism[49].
Measurements of these metabolites will reveal the biochemi-
cal status of an organism and in turn can be used to monitor
andassessgenefunction.Itisestablishedthatimprovedtech-
nology such as proteomics, transcriptomics, and genomics
oﬀer the platform to bridge traditional medicine and molec-
ular pharmacology [50], assess bioactivity of traditional pro-
ducts [15], and study the biochemical eﬀects on bioactive
compounds on human subjects [51]. Metabolomics is con-
cerned with the high throughput identiﬁcation and quan-
tiﬁcation of small molecule (<1500Da) metabolites [52]a n d
has hence emerged as a more robust approach in predicting
gene activity as aﬀected by interaction with foods, than the
currently more widely used transcriptomic and proteomic
approaches. Gene expression and proteomic data only indi-
cate potential of physiological changes. Data generated deliv-
ered interesting insights for the understanding of metabolic
responses of human as aﬀected by dietary interventions [53].
Mostoftheworkinmetabolomicshasfocusedonclinical
or pharmaceutical applications such as drug discovery, drug
assessment,clinicaltoxicology,anddiseasesstates[54].How-
ever, over the past few years, metabolomics has also emerged
asaﬁeldofincreasinginteresttofoodandnutritionscientists
[55]. With regard to natural product research, metabolomics
in the context of systems biology is seen as a bridge linking
Traditional Chinese Medicine (TCM) and molecular phar-
macology [50]. Metabolomics has been applied to improve
identiﬁcation of bioactive metabolites from extracts [56],
to study the biochemical eﬀects of bioactive compounds in
human subjects [50], for quality control of phytomedicines
[56], and to assess their toxicity [57]. One of the ﬁrst
studies to use metabolomic techniques in a diet-intervention
trial involved studing the eﬀects of soy-derived proteins
and soy isoﬂavones in healthy premenopausal women under
controlledenvironmentalconditions[51].NMRandchemo-
metric techniques were used to analyze the blood plasma
proﬁle changes in premenopausal women on a multiweek
soy diet. The results showed that signiﬁcant diﬀerences could
be detected in lipoproteins, amino acid, and carbohydrate
proﬁles that related to metabolic pathways responsible for
osmolyteﬂuctuationandenergymetabolism.Asimilarstudy
by Fardet and colleagues [58] explored the inﬂuence of
whole-grain and wheat ﬂour diets on rats using NMR-based
methods. These studies showed that the whole-grain-fed
animals had higher urinary levels of Kreb’s cycle interme-
diates, aromatic acids, and hippuric acid. NMR studies on
plasma and liver showed increases in glutathione (reduced)
and betaine, which are general indicators of good redox
status and lower oxidative stress. Others include studies on
the eﬀects of fruits and vegetables diversity on the levels of
oxidative biomarkers [59], the inﬂuence of concentrated red
grape juice on oxidative stress, lipidemic, and inﬂammatory
markers in blood [60], the eﬀect of extra virgin olive
oil on plasma inﬂammatory and oxidative stress markers
[61], the consequences of macadamia nut consumption on
cardiovascular disease [62], and the inﬂuence of gazpacho
soup consumption on plasma biomarkers of oxidative and
inﬂammatory stress [63]. Galphimia glauca,aM e x i c a np l a n t
has been traditionally used to treat diseases of the central
nervous system but therapeutic eﬀects of the plants tend to
vary with geographical locations. Animals testing reported
anxiolytic and sedative activities, with only 2 out of the 6 col-
lections used showing high bioactivity. The metabolic proﬁl-
ing of the extracts was then performed using 1HN M Ra n d
partial least square-discriminant analysis. Results attributed
the bioactivity to the presence of galphimine, present in
the 2 active extracts and lacking in the less active remain-
ing 4. There was a strong correlation between anxiolytic
and sedative eﬀects and metabolic proﬁles of plants, showing
that metabolomics can be successfully used to identify novel
drug compound from pants [64]. In another study, Jiang and
coworkers studied the metabolic proﬁling and phylogenetic
analysis of medicinal Zingiber species. The plants species
derived from diﬀerent origin showed no diﬀerence in qual-
itative metabolites although quantitative diﬀerences were
detected through GC-MS. The anti-inﬂammatory activities
of the diﬀerent species were also determined. There was a
lack of correlation between gingerol found in Z. oﬃcinale
and anti-inﬂammatory activities, suggesting that other com-
pounds in Zingiber species might be responsible for the
anti-inﬂammatory activities. Thesecompounds remaintobe
elucidated [65]. The use of metabolomics to prove eﬃcacy
and unravel mechanism of action of natural compounds is
fast gaining popularity, both in animal and human studies.
The eﬀect of a traditional and popular antiageing agent,
Herba epimedii, was evaluated using 1HN M Ra n dP C A
techniques. Ten metabolites of interest were identiﬁed as
antiageing biomarkers in the urine of rats. Further studies
carried out after intervention with the ﬂavones of Herba
epimedii revealed that the urine proﬁle of 24-month-old rats
shifted to that of 18-month-old models [66]. In relation
to obesity, metabolomics has been used to assess the eﬀect
of obesity in a rat model of obesity induced by a high-fat
diet. The metabolic changes in the urine of high-fat-diet-
induced obese rats using 1H-nuclear magnetic resonance
spectroscopy-basedmetabolicassessmentwerereported.The
spectrawereanalyzedusingmultivariatestatisticalanalysisto
identify the separation of groups. Multivariate data analysis
deals with the statistical analysis of thousands of variables at6 The Scientiﬁc World Journal
a time. In most cases of metabolomics studies, the number
of observations is considerably smaller than the measured
variables. The metabolic proﬁle of urine was diﬀerent in low
gainers and high gainers on the same diet. Metabolites of
interest include betaine, taurine, acetone/acetoacetate, phe-
nylacetylglycine, pyruvate, lactate, and citrate. This study
successfully conﬁrms the accuracy of NMR-based meta-
bolomics to study the eﬀect of diet on obesity [67].
Another study attempted to study childhood obesity
from a metabolomic perspective. Zheng and colleagues have
recently carried out a plasma metabolic ﬁngerprinting of
childhood obesity by GC/MS in conjunction with multi-
variate statistical analysis. Plasma from normal, overweight
and obese children was subjected for metabolic proﬁling
using GC/MS. Diﬀerent metabolic patterns were revealed
as computed by uncorrelated linear discriminant analysis.
Isoleucine, glyceric acid, serine, 2,3,4-trihydroxybutyric acid,
and phenylalanine were discovered as potential biomarkers
for childhood obesity. The authors also reported that waist
hip ratio, total triglycerides, total cholesterol, high-density
lipoprotein, and low-density lipoprotein were closely related
to metabolic perturbations of childhood obesity and advised
that these components to be given more importance in the
clinical setting rather than BMI alone [68].
In spite of the increasing use of metabolomics tech-
niques in natural health product research, there is limited
informationavailableondietaryphytochemicalstrategiesfor
obesity and obesity-linked diseases using the metabolomics
approach. To the best of our knowledge, there is no study
reporting the metabolite modulation of obese subjects fed
a high-fat diet, supplemented with natural bioactives. But,
metabolomics being still in its infancy when it concerns nat-
ural product research, there is no doubt that more and more
information will become available on antiobesity eﬀects of
plants’ bioactives, from a metabolic perspective.
6. Conclusion
The popularity of alternative medicine is increasing by leaps
and bounds as shown by the increase in demand of natural
health products. As drugs failed to give desirable long-term
results, more and more interest is generated in the use of
medicinal plants to alleviate obesity. Various plants and
natural products have been assessed for their potential an-
tiobesity eﬀect both in vitro and in vivo. There is increasing
proof that plants and their products can exert antiobesity
eﬀects through various mechanisms such as antilipase, anti
adipogenesis eﬀect, or suppressing appetite. Some research-
ers also suggest that a synergy between diﬀerent plants give
ab e t t e re ﬀect in terms of antiobesity as compared to the
single plants. The major drawback is the questionable eﬀect
in human subjects. Results from in vitro or in vivo animal
models cannot be directly extrapolated to human subjects
and in many cases are found to be not signiﬁcantly eﬀective.
There is always the risk of toxicity, lack of information on
mechanisms of action, and poor quality control of natural
herbalantiobesityproducts.Recentadvancesinsystemsbiol-
ogyresearch,suchasmetabolomics,haveenabledresearchers
to identify bioactive compounds, assess bioactivity, and
elucidate mechanisms of therapeutic action and toxic eﬀects
and to maintain quality control more accurately. Medicinal
plants as antiobesity agents are gaining more credibility in
the scientiﬁc community and some of the natural com-
pounds have reached clinical trials (e.g., P57 from H. gor-
donii).Without anydoubt, thereis apotential ofusing plants
and their products as a therapeutic treatment to manage
obesity. There are also thousands of unstudied plants across
the world, some of which have traditionally been used to
maintain ideal body weight or as slimming agents, thus justi-
fying the need for deeper research in this ﬁeld. Nonetheless,
sound methodologies are the key to provide scientiﬁcally
valid and sound information so that these plants or com-
pounds make it as antiobesity agents in the clinical setting.
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